title: Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
authors.forename: Hanako
authors.initials: H
authors.lastname: Ohmatsu
authors.forename: Makoto
authors.initials: M
authors.lastname: Sugaya
authors.forename: Hiraku
authors.initials: H
authors.lastname: Suga
authors.forename: Sohshi
authors.initials: S
authors.lastname: Morimura
authors.forename: Tomomitsu
authors.initials: T
authors.lastname: Miyagaki
authors.forename: Hiromichi
authors.initials: H
authors.lastname: Kai
authors.forename: Shinji
authors.initials: S
authors.lastname: Kagami
authors.forename: Hideki
authors.initials: H
authors.lastname: Fujita
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Asano
authors.forename: Yayoi
authors.initials: Y
authors.lastname: Tada
authors.forename: Takafumi
authors.initials: T
authors.lastname: Kadono
authors.forename: Shinichi
authors.initials: S
authors.lastname: Sato
mesh_terms: D000328:Adult; D000368:Aged; D003876:Dermatitis, Atopic / Q000097:blood; D006801:Humans; D007378:Interleukins / Q000097:blood*; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000097:blood* / Q000473:pathology; D009367:Neoplasm Staging; D012720:Severity of Illness Index; D012751:Sezary Syndrome / Q000097:blood* / Q000473:pathology; D012878:Skin Neoplasms / Q000097:blood* / Q000473:pathology; D055815:Young Adult
chemical_list: C502187:IL31 protein, human; D007378:Interleukins